# Study of HS-10384 in Participants of Chinese Postmenopausal Women

> **NCT06122181** · PHASE1 · UNKNOWN · sponsor: **Hansoh BioMedical R&D Company** · enrollment: 48 (estimated)

## Conditions studied

- Vasomotor Symptoms

## Interventions

- **DRUG:** HS-10384 tablets
- **DRUG:** HS-10384-matched placebo tablets

## Key facts

- **NCT ID:** NCT06122181
- **Lead sponsor:** Hansoh BioMedical R&D Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-12
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06122181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06122181, "Study of HS-10384 in Participants of Chinese Postmenopausal Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06122181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*